MICHAEL STONE: Open Payments
NPI 1821017252 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 29 payments from 12 companies in 2025. Trend: 2023 $532 · 2024 $678 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $166 |
| ABBVIE INC. | 5 | $82 |
| Novo Nordisk Inc | 4 | $77 |
| Ardelyx, Inc. | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 1 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Viatris Specialty LLC | 1 | $14 |
Products named: CAPLYTA, IBSRELA, FANAPT, VRAYLAR, UBRELVY, Rybelsus, GVOKE HYPOPEN, Ozempic.
Industry payments across TN — which companies pay providers there.
